Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes

Am J Med. 2003 Dec 1;115(8):613-9. doi: 10.1016/j.amjmed.2003.08.007.

Abstract

Purpose: To investigate the prognostic importance of new small Q waves following an acute coronary syndrome.

Methods: We assessed 6-month mortality in 10501 patients with non-ST-elevation acute coronary syndromes who had survived 30 days and had both admission and 30-day electrocardiograms. Patients were stratified by whether they had no new Q waves (n = 9447), new 30- to 40-ms Q waves (n = 733), or new > or =40-ms Q waves (n = 321).

Results: Mortality was higher in patients with 30- to 40-ms Q waves than in those with no new Q waves (3.4% [25/733] vs. 2.4% [227/9447], P = 0.005), and even higher in those with > or =40-ms Q waves (5.3% [17/321], P = 0.002). After adjustment for baseline risk predictors, mortality remained higher in patients with new 30- to 40-ms Q waves (odds ratio [OR] = 1.30; 95% confidence interval [CI]: 0.85 to 1.98; P = 0.23) and those with new > or =40-ms Q waves (OR = 1.87; 95% CI: 1.13 to 3.09; P = 0.01).

Conclusion: Patients with new small Q waves following a non-ST-elevation acute coronary syndrome are at increased risk of adverse outcomes. These small Q waves should be considered diagnostic of myocardial infarction. Further research should investigate whether even smaller QRS changes are prognostically important.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Confidence Intervals
  • Coronary Angiography / statistics & numerical data
  • Coronary Disease / diagnosis*
  • Coronary Disease / metabolism
  • Coronary Disease / mortality*
  • Coronary Disease / therapy
  • Creatine Kinase / analysis
  • Creatine Kinase, MB Form
  • Electrocardiography*
  • Eptifibatide
  • Female
  • Heart Failure / mortality
  • Humans
  • Isoenzymes / analysis
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / therapy
  • Myocardial Revascularization / statistics & numerical data
  • Odds Ratio
  • Peptides / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prognosis
  • Survival Analysis
  • Survival Rate
  • Syndrome
  • Ventricular Dysfunction, Left / mortality

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Isoenzymes
  • Peptides
  • Platelet Aggregation Inhibitors
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Eptifibatide